Skip to main content
Journal cover image

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

Publication ,  Journal Article
Chen, RC; Chang, P; Vetter, RJ; Lukka, H; Stokes, WA; Sanda, MG; Watkins-Bruner, D; Reeve, BB; Sandler, HM
Published in: J Natl Cancer Inst
July 2014

The National Cancer Institute (NCI) Symptom Management and Health-Related Quality of Life Steering Committee convened four working groups to recommend core sets of patient-reported outcomes to be routinely incorporated in clinical trials. The Prostate Cancer Working Group included physicians, researchers, and a patient advocate. The group's process included 1) a systematic literature review to determine the prevalence and severity of symptoms, 2) a multistakeholder meeting sponsored by the NCI to review the evidence and build consensus, and 3) a postmeeting expert panel synthesis of findings to finalize recommendations. Five domains were recommended for localized prostate cancer: urinary incontinence, urinary obstruction and irritation, bowel-related symptoms, sexual dysfunction, and hormonal symptoms. Four domains were recommended for advanced prostate cancer: pain, fatigue, mental well-being, and physical well-being. Additional domains for consideration include decisional regret, satisfaction with care, and anxiety related to prostate cancer. These recommendations have been endorsed by the NCI for implementation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

July 2014

Volume

106

Issue

7

Location

United States

Related Subject Headings

  • Visceral Pain
  • Urinary Retention
  • Urinary Incontinence
  • United States
  • Treatment Outcome
  • Surveys and Questionnaires
  • Severity of Illness Index
  • Self Report
  • Quality of Life
  • Prostatic Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, R. C., Chang, P., Vetter, R. J., Lukka, H., Stokes, W. A., Sanda, M. G., … Sandler, H. M. (2014). Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst, 106(7). https://doi.org/10.1093/jnci/dju132
Chen, Ronald C., Peter Chang, Richard J. Vetter, Himansu Lukka, William A. Stokes, Martin G. Sanda, Deborah Watkins-Bruner, Bryce B. Reeve, and Howard M. Sandler. “Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.J Natl Cancer Inst 106, no. 7 (July 2014). https://doi.org/10.1093/jnci/dju132.
Chen RC, Chang P, Vetter RJ, Lukka H, Stokes WA, Sanda MG, et al. Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst. 2014 Jul;106(7).
Chen, Ronald C., et al. “Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.J Natl Cancer Inst, vol. 106, no. 7, July 2014. Pubmed, doi:10.1093/jnci/dju132.
Chen RC, Chang P, Vetter RJ, Lukka H, Stokes WA, Sanda MG, Watkins-Bruner D, Reeve BB, Sandler HM. Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst. 2014 Jul;106(7).
Journal cover image

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

July 2014

Volume

106

Issue

7

Location

United States

Related Subject Headings

  • Visceral Pain
  • Urinary Retention
  • Urinary Incontinence
  • United States
  • Treatment Outcome
  • Surveys and Questionnaires
  • Severity of Illness Index
  • Self Report
  • Quality of Life
  • Prostatic Neoplasms